Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

M. González Cao; S. Viteri; C. Garrán; Y. Nieto; J. Aristu; M. Ponz; S. Martín Algarra

doi:10.1007/s12094-007-0023-6

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

M. González Cao, S. Viteri, C. Garrán, Y. Nieto, J. Aristu, M. Ponz, S. Martín Algarra

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

We report here a taxol-bevacizumab-responsive metastatic melanoma case. Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.

Original language	English (US)
Pages (from-to)	119-120
Number of pages	2
Journal	Clinical and Translational Oncology
Volume	9
Issue number	2
DOIs	https://doi.org/10.1007/s12094-007-0023-6
State	Published - 2007
Externally published	Yes

Keywords

Bevacizumab
Melanoma
Taxol

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/s12094-007-0023-6

Cite this

@article{dfff2d4659ac4cd1a42eaf845650ab50,

title = "Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab",

abstract = "We report here a taxol-bevacizumab-responsive metastatic melanoma case. Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.",

keywords = "Bevacizumab, Melanoma, Taxol",

author = "{Gonz{\'a}lez Cao}, M. and S. Viteri and C. Garr{\'a}n and Y. Nieto and J. Aristu and M. Ponz and {Mart{\'i}n Algarra}, S.",

year = "2007",

doi = "10.1007/s12094-007-0023-6",

language = "English (US)",

volume = "9",

pages = "119--120",

journal = "Clinical and Translational Oncology",

issn = "1699-048X",

publisher = "Springer-Verlag Italia",

number = "2",

}

TY - JOUR

T1 - Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

AU - González Cao, M.

AU - Viteri, S.

AU - Garrán, C.

AU - Nieto, Y.

AU - Aristu, J.

AU - Ponz, M.

AU - Martín Algarra, S.

PY - 2007

Y1 - 2007

N2 - We report here a taxol-bevacizumab-responsive metastatic melanoma case. Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.

AB - We report here a taxol-bevacizumab-responsive metastatic melanoma case. Although the patient had been heavily pretreated for two years, she did not show any stabilisation or objective response of her disease. After treatment with taxol and bevacizumab combination an impressive response was obtained.

KW - Bevacizumab

KW - Melanoma

KW - Taxol

UR - http://www.scopus.com/inward/record.url?scp=34347211811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347211811&partnerID=8YFLogxK

U2 - 10.1007/s12094-007-0023-6

DO - 10.1007/s12094-007-0023-6

M3 - Article

C2 - 17329225

AN - SCOPUS:34347211811

SN - 1699-048X

VL - 9

SP - 119

EP - 120

JO - Clinical and Translational Oncology

JF - Clinical and Translational Oncology

IS - 2

ER -

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this